Form D — Renovare Therapeutics, Inc.
0002158361-26-000001 · filed Oct 2, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $1,000,000
- Total sold
- $100,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Renovare Therapeutics, Inc.
- CIK
- 2158361
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2026
- Address
- 8871 TAHOE COURT
BOULDER, CO 80301 - Phone
- 919-381-7314
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Elizabeth A Scott · Executive OfficerBoulder, CO Find on LinkedIn ↗
-
Stephanie Bryant · DirectorBoulder, CO Find on LinkedIn ↗
-
Karin Payne · Executive OfficerBoulder, CO Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗